Evidence map›Paper›PMID 33946462›Full record

SynthesisMedicina (Kaunas, Lithuania)2021

The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.

Roberta Angelico, Francesca Blasi, Tommaso Maria Manzia, Luca Toti, Giuseppe Tisone, Roberto Cacciola

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05629923 (EVALUATION OF COVID-19 VACCINATION EFFICACY AND CONTIXAGEVIMAB-CILGAVIMAB PROPHYLAXIS IN LIVER AND KIDNEY TRANSPLANT PATIENTS), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05629923 completednot on this mapstarted 2022, after this paper: background citation

Evaluation of covid-19 vaccination efficacy and contixagevimab-cilgavimab prophylaxis in liver and kidney transplant patients: preliminary study

TypeobservationalSponsorUniversity of Rome Tor VergataRan2022 to 2022Enrolled306ConditionsCOVID-19 Pandemic, Transplant-Related DisorderArmstixagevimab-cilgavimab(AZD7442, AstraZeneca)
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. COVID-19 and solid organ transplantation: Finding the right balance.Transplantation reviews (Orlando, Fla.) · 2022
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. COVID-19 and the kidney: time to take a closer look.International urology and nephrology · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Roberta AngelicoDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-3439-7750
Francesca BlasiDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
Tommaso Maria ManziaDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
Luca TotiDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
Giuseppe TisoneDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
Roberto CacciolaDepartment of Surgery Sciences, Transplant and HPB Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Kidney TransplantationHumansImmunosuppression TherapyImmunosuppressive AgentsSARS-CoV-2Immunosuppressive Agentsallograft outcomescomplicationscoronavirus disease 2019immunosuppressionkidney transplantationpatient outcomessevere acute respiratory syndrome coronavirus 2

Identifiers

PMID33946462
PMCPMC8147172
OpenAlexW3159395288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.